Why NuVasive Stock Gained 14% in July
Earnings strength led to a profit upgrade from the medical device giant last month.
NuVasive
NUVA
NUVA
$66.53
$1.24
1.9%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive NUVA Charts
NuVasive develops and markets minimally invasive products and related solutions for spinal surgeries.
News & Analysis: NuVasive
The Fool has written over 100 articles on NuVasive.
Why NuVasive Stock Is Shooting Higher Today
Shares jump after the medical device maker reported upbeat second-quarter results. Here's what investors need to know.
NuVasive Inc (NUVA) Q2 2019 Earnings Call Transcript
NUVA earnings call for the period ending June 30, 2019.
NuVasive Sees a Healthier Future
Higher guidance from the spinal surgery specialist was encouraging.
NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript
NUVA earnings call for the period ending March 31, 2019.
NuVasive Straightens Up to Start 2019
The spinal-surgery specialist gave investors solid performance.
Why NuVasive Stock Rose 18% in February
The spinal surgery specialist gained market share last year and expects to repeat that success in 2019.
NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript
NUVA earnings call for the period ending December 31, 2018.
NuVasive Overcomes Industry Headwinds to Finish 2018 Strong
Some revenue weakness didn't hold back the spinal surgery specialist's bottom-line growth.
Why NuVasive, Avis Budget Group, and Insperity Jumped Today
Find out what helped these stocks beat a mixed market.
